Synapticure Inc.’s Post

Are you, too, heading for AD/PD 2024 in Lisbon, Portugal? 👋 Come meet our #teamfujirebio with experts from Marketing, Sales and R&D (see comments 👇 for details) who are eager to discuss the latest within the field of neurodegenerative disease testing - find us at booth 6 👉 https://lnkd.in/eMZcHtum #ADPD #neurodegeneration #alzheimersdisease #parkinsonsdisease

Elated to share that i have successfully presented my Research Paper titled "Development of Supervised Algorithm for Predicting Chronic Kidney Disease" in IC2PCT Conference. All thanks to #galgotiasuniversity for providing me with this wonderful opportunity! #ieeexplore #galgotiasuniversity #researchpaper

April is Parkinson's Awareness Month! 🤍 This special month aims to raise awareness on #ParkinsonsDisease and recognize its symptoms or early signs that can lead to an earlier diagnosis and overall better quality of life! Start learning more about Parkinson's Disease this month to spread the word and advance PD research. Check out our currently open Parkinson's clinical trials conducted by our Principal Investigators, Dr. Anna Morenkova and Dr. Nicolas Phielipp: https://bit.ly/3MDKIiG

Thanks MIT School of Engineering for covering my research!

🌷🎗️April 11th marks #worldparkinsonsday🌍, a day to raise awareness and understanding of Parkinson's internationally. Today we celebrate the incredible research happening worldwide that is working towards finding a cure and helping to improve the quality of life for those living with Parkinson's. We've been chatting to Maggie Kuhl, Vice President of Patient Engagement at The Michael J Fox Foundation for Parkinson's Research about the significance of World Parkinson's Day, and we've seized the opportunity to spotlight the Foundation's landmark PPMI study, including Smell Test Direct, a study supported by uMed that's investigating the link between Smell loss and brain disease. #parkinsonsresearch #parkinsonsawareness #parkinsonsawarenessmonth #clinicalresearch #ppmi

Did you know April is National #MinorityHealth Month? Every year, #NMHM builds awareness around the disproportionate burden of premature death and illness in people from racial and ethnic minority groups and encourages action through health education, early detection, and control of disease complications. #ArteraAI models - developed using clinical trial data comprised of approximately 20% African Americans (a historically underrepresented group in clinical trials) - can predict therapeutic benefit and estimate long-term outcomes to support personalized treatment decision-making. ➡️ Learn more about how we're shaping the future of cancer treatment decisions at artera.ai. #NationalMinorityHealthMonth #NMHM24

Emphasizing the importance of cancer awareness – from understanding causes, symptoms & treatment options to the different types. Let's unite in educating & spreading awareness about this critical health concern. Together, we can make a difference! 🌟🎗️ ZEE Business #CancerAwareness #ZeeBusinessNews #WorldCancerDay #CancerTreatment #KnowledgeIsPower #DrSameerBhati STAR IMAGING AND PATH LAB

Join us for to hear Dr. Marwan Sabbagh MD, FAAN speak about leveraging interdisciplinary collaboration for prompt ID and optimal patient management of Early-Stage Alzheimer's Disease. Learning objectives: • Implement strategies to overcome barriers to timely diagnosis of Alzheimer’s disease, addressing stigma, applying quantitative assessments, and integrating neuroimaging as well as specialty referral in clinical assessment • Formulate strategies to optimize multidisciplinary communication and specialty referral • Incorporate updates in clinical data to inform the identification of AD early in the disease process • Implement shared decision-making (SDM) approaches to facilitate diagnosis and optimize management #PALH #CME

Join us for to hear Dr. Marwan Sabbagh MD, FAAN speak about leveraging interdisciplinary collaboration for prompt ID and optimal patient management of Early-Stage Alzheimer's Disease. Learning objectives: • Implement strategies to overcome barriers to timely diagnosis of Alzheimer’s disease, addressing stigma, applying quantitative assessments, and integrating neuroimaging as well as specialty referral in clinical assessment • Formulate strategies to optimize multidisciplinary communication and specialty referral • Incorporate updates in clinical data to inform the identification of AD early in the disease process • Implement shared decision-making (SDM) approaches to facilitate diagnosis and optimize management #PALH #CME

Reisa Sperling, MD, Chris Van Dyck, MD, Dennis Selkoe, MD, and Larisa Reyderman, PhD, will be sharing our latest Alzheimer’s disease (AD) clinical data in Hall A today at #AAIC24 at 4:15 PM ET. Join us to hear the latest updates. #AlzheimersDisease #EndAlz